Low-Dose Sirolimus Immunoregulation Therapy in Patients with Active Rheumatoid Arthritis: A 24-Week Follow-Up of the Randomized, Open-Label, Parallel-Controlled Trial

por Wen, Hong-Yan, Wang, Jia, Zhang, Sheng-Xiao, Luo, Jing, Zhao, Xiang-Cong, Zhang, Chen, Wang, Cai-Hong, Hu, Fang-Yuan, Zheng, Xiao-Juan, Cheng, Ting, Niu, Hong-Qing, Liu, Guang-Ying, Yang, Wen-Xian, Yu, Na-Na, Ru, Jin-Li, Chen, Qi-Xiang, Lu, Xue-Chun, He, Pei-Feng, Gao, Chong, Li, Xiao-Feng
Publicado 2019